Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Oral semaglutide in HFpEF: Real-world evidence and causal considerations. | Pepdox

Home
Search
PMID 40716975

Oral semaglutide in HFpEF: Real-world evidence and causal considerations.

European journal of internal medicine2025PMID: 40716975

View on PubMed DOI: 10.1016/j.ejim.2025.07.024

Authors

Catalán, Victoria; Frühbeck, Gema; Gómez-Ambrosi, Javier

Keywords

GLP-1R agonistsHFpEFObesityOral semaglutideSemaglutideType 2 diabetesWeight loss